荣泰健康
(603579)
| 流通市值：64.83亿 | | | 总市值：64.83亿 |
| 流通股本：2.03亿 | | | 总股本：2.03亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 810,202,891.61 | 394,971,319.77 | 1,596,868,348.54 | 1,164,316,596.07 |
| 营业收入 | 810,202,891.61 | 394,971,319.77 | 1,596,868,348.54 | 1,164,316,596.07 |
| 二、营业总成本 | 751,180,423.4 | 359,966,503.86 | 1,435,026,128.54 | 1,027,733,709.64 |
| 营业成本 | 546,841,588.52 | 266,434,319.74 | 1,090,976,703.61 | 786,711,497.71 |
| 税金及附加 | 14,742,388.11 | 4,904,582.46 | 13,548,506.3 | 9,870,840.75 |
| 销售费用 | 93,630,050.8 | 42,292,214.01 | 179,603,370.11 | 125,232,032.89 |
| 管理费用 | 39,474,362.13 | 19,462,326.83 | 86,713,089.22 | 57,521,268.96 |
| 研发费用 | 44,021,424.86 | 21,310,597.42 | 80,104,026.4 | 57,007,658.8 |
| 财务费用 | 12,470,608.98 | 5,562,463.4 | -15,919,567.1 | -8,609,589.47 |
| 其中:利息费用 | 16,306,851.36 | 7,360,620.7 | 5,901,938.34 | 3,591,417.78 |
| 其中:利息收入 | 3,896,421.02 | 1,955,899.34 | 15,044,827.35 | 12,631,875.27 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 213,254.07 | 2,556,694.34 | -6,141,569.1 | -920,780.53 |
| 加:投资收益 | 29,957,204.55 | 12,665,617.75 | 38,839,839.16 | 18,344,311.54 |
| 资产处置收益 | 220,885.15 | 226,210.51 | 703,339.52 | -109,812.47 |
| 资产减值损失(新) | -1,707,794.53 | - | -5,046,504.18 | -1,910,238.52 |
| 信用减值损失(新) | 772,703.08 | -692,957.59 | 914,913.83 | -1,436,988.53 |
| 其他收益 | 19,703,572.16 | 3,488,669.46 | 19,288,241.83 | 7,290,170.52 |
| 四、营业利润 | 108,182,292.69 | 53,249,050.38 | 210,400,481.06 | 157,839,548.44 |
| 加:营业外收入 | 25,203.83 | 13,573.71 | 233,169.93 | 124,278.85 |
| 减:营业外支出 | -1,133,857.94 | 281,964.68 | 639,531.66 | 380,085.09 |
| 五、利润总额 | 109,341,354.46 | 52,980,659.41 | 209,994,119.33 | 157,583,742.2 |
| 减:所得税费用 | 23,793,094.39 | 8,982,423.3 | 18,186,266.5 | 14,791,959.18 |
| 六、净利润 | 85,548,260.07 | 43,998,236.11 | 191,807,852.83 | 142,791,783.02 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 85,548,260.07 | 43,998,236.11 | 191,807,852.83 | 142,791,783.02 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 85,336,914.36 | 43,938,868.26 | 191,945,865.16 | 142,512,054.98 |
| 少数股东损益 | 211,345.71 | 59,367.85 | -138,012.33 | 279,728.04 |
| 扣除非经常损益后的净利润 | 55,949,765.99 | 32,466,233.42 | 163,207,478.98 | 126,776,800.46 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.49 | 0.25 | 1.11 | 0.82 |
| (二)稀释每股收益 | 0.49 | 0.24 | 0.97 | 0.72 |
| 八、其他综合收益 | 29,992,577.05 | 24,113,355.17 | 17,456,935.93 | -7,756,276.24 |
| 归属于母公司股东的其他综合收益 | 29,882,076.7 | 24,131,118.94 | 17,493,057.54 | -7,715,397.18 |
| 九、综合收益总额 | 115,540,837.12 | 68,111,591.28 | 209,264,788.76 | 135,035,506.78 |
| 归属于母公司股东的综合收益总额 | 115,218,991.06 | 68,069,987.2 | 209,438,922.7 | 134,796,657.8 |
| 归属于少数股东的综合收益总额 | 321,846.06 | 41,604.08 | -174,133.94 | 238,848.98 |
| 公告日期 | 2025-08-28 | 2025-04-24 | 2025-04-24 | 2024-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |